SCHEMBL27937598

SCHEMBL27937598

Cc1nc(Nc2nc(N3CCC(=O)CC3)cc(N3CCN(C)CC3)n2)sc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 6/20 0.52
ALDH1A1 P00352 4/20 0.43
HPGD P15428 1/20 0.43
AURKA O14965 2/20 0.41
TSHR P16473 1/20 0.40
CCNT1 O60563 4/20 0.39
CDK4 P11802 4/20 0.39
CCND1 P24385 4/20 0.39
CDK9 P50750 4/20 0.39
CDK6 Q00534 4/20 0.39
CDK11A Q9UQ88 4/20 0.39
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
HIF1A Q16665 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HRH4 Q9H3N8 1/20 0.37
ABL1 P00519 1/20 0.37
SIK1 P57059 1/20 0.37
SIK2 Q9H0K1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26647638 0.94 PDE5A (0.57) PDE5AALDH1A1HPGDAURKATSHR
SCHEMBL291604 0.87 PDE5A (0.70) PDE5AALDH1A1HPGDMAPTLMNA
SCHEMBL29832127 0.87 PDE5A (0.70) PDE5AALDH1A1HPGDMAPTLMNA
SCHEMBL27950966 0.87 PDE5A (0.69) PDE5AALDH1A1HPGDAURKATSHR
SCHEMBL299899 0.86 PDE5A (0.47) PDE5AALDH1A1HPGDAURKATSHR
SCHEMBL27950945 0.86 PDE5A (0.57) PDE5AALDH1A1HPGDAURKATSHR
SCHEMBL27950943 0.86 PDE5A (0.50) PDE5AALDH1A1HPGDAURKATSHR
SCHEMBL300054 0.84 PDE5A (0.52) PDE5AALDH1A1AURKATSHRMAPT
SCHEMBL290899 0.82 PDE5A (0.53) PDE5AALDH1A1HPGDAURKATSHR
SCHEMBL28020392 0.81 AURKA (0.48) PDE5AALDH1A1HPGDAURKAHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103547267-A Treatment of addiction and impulse control disorders using PDE7 inhibitors OMEROS CORP 2014-01-29 CN disclosed